Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-01-31
1995-07-18
Warden, Jill
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 530324, 530325, 530326, C07K 1400, C07K 14435, A61K 3817, A61K 3816
Patent
active
054341337
ABSTRACT:
Novel peptides represented by the general formula: ##STR1## and physiologically acceptable acid addition salts thereof; where (A) represents H-, H-Gly, H-Lys-Gly, H-Ser-Lys-Gly, H-Leu-Ser-Lys-Gly, H-Gly-Leu-Ser-Lys-Gly, H-ser, H-Ser-Ser, H-Arg-Ser-Ser, H-Arg-Arg-Ser-Ser, H-Leu-Arg-Arg-Ser-Ser, H-Ser-Leu-Arg-Arg-Ser-Ser;
(B) represents H-Cys or Pmp;
(C) represents Phe-, pCl-Phe, pF-Phe, pNO.sub.2 -Phe or Cha;
(D) represents Ile, Val, Aib, tLeu, Gly or Leu;
(E) represents Lys or Arg;
(F) represents Ile, Leu or Met;
(G) represents Ser or Ala;
(H) represents Met or Gln;
(I) represents --OH, -Asn-OH, -Asn-Ser-OH, -Asn-Ser-Phe-OH, -Asn-Ser-Phe-Arg-OH or -Asn-Ser-Phe-Arg-Tyr-OH; and the symbol " . . . " represents a disulfide bond;
provided that 1) .alpha.-hANP, 2) .alpha.-hANP (7-28) and 3) CNP-22 are excluded from the scope of that general formula.
Also disclosed are agents for suppressing the growth of vascular smooth muscle cells that contains those peptides as effective ingredients.
REFERENCES:
Sudoh et al. Biochem. Biophys. Res. Commun. (1990) 168:863-870.
Kangawa et al. Biochem. Biophys. Res. Commun. (1984) 118:131-139.
Mayumi Furuya et al., "C-Type Natriuretic Peptide is a Growth Inhibitor of Rat Vascular Smooth Muscle Cells", Biochmical And Biophysical Research Communications, vol. 177, No. 3, 1991, Jun. 28, 1991, pp. 927-931.
Mayumi Furuya, et al. "C-Type Natriuretic Peptide Inhibits Intimal Thickening After Vascular Injury", Biochemical And Biophysical Research Communications, vol. 193, No. 1, 1993, May 28, 1993, pp. 248-253.
Chemical Abstracts, vol. 113, No. 3, Jul. 16, 1990; Chemical Abstracts, vol. 113, No. 11, Sep. 10, 1990; Chemical Abstracts, vol. 113, No. 23, Dec. 3, 1990.
Furuya Mayumi
Kitajima Yasuo
Matsuo Hisayuki
Minamitake Yoshiharu
Tanaka Shoji
Matsuo Hisayuki
Salata Carol A.
Suntory Limited
Warden Jill
LandOfFree
CNP analog peptides and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CNP analog peptides and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CNP analog peptides and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2419022